Advanced in IgG4-Related Disease

Dr. Abigail R. Neiman

Rheumatology
902 Frostwood Dr, Suite 311, 
Houston, TX 
Accepting New Patients
Offers Telehealth

Advanced in IgG4-Related Disease
902 Frostwood Dr, Suite 311, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Abigail Neiman is a Rheumatologist in Houston, Texas. Dr. Neiman is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Gout, Fibromyalgia, Rheumatoid Arthritis (RA), and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Neiman is currently accepting new patients.

Her clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in TX
Hospital Affiliations
Memorial Hermann Memorial City Hospital
Memorial Hermann Katy Hospital
Memorial Hermann Hospital System
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

902 Frostwood Dr, Suite 311, Houston, TX 77024
Call: 713-932-0054

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Biological, Drug
Study Drugs: Pegloticase, Methotrexate
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Enrollment Status: Completed
Publish Date: January 07, 2025
Intervention Type: Biological
Study Drugs: Pegloticase, MTX
Study Phase: Phase 4
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug, Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Advanced in IgG4-Related Disease
Dr. Nicole A. Hunt
Rheumatology
Advanced in IgG4-Related Disease
Dr. Nicole A. Hunt
Rheumatology

Kelsey-Seybold Medical Group, PLLC

2515 Business Ctr Dr, 
Pearland, TX 
 (17.6 miles away)
713-442-7200
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Nicole Hunt is a Rheumatologist in Pearland, Texas. Dr. Hunt is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Undifferentiated Connective Tissue Disease (UCTD), IgG4-Related Disease, Light Chain Deposition Disease (LCDD), and MAGIC Syndrome. Dr. Hunt is currently accepting new patients.

Advanced in IgG4-Related Disease
Dr. Wajeeha Yousaf
Rheumatology
Advanced in IgG4-Related Disease
Dr. Wajeeha Yousaf
Rheumatology
6300 W Loop S, Suite 333, 
Bellaire, TX 
 (7.4 miles away)
313-685-0052
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Wajeeha Yousaf is a Rheumatologist in Bellaire, Texas. Dr. Yousaf is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are MAGIC Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, Light Chain Deposition Disease (LCDD), and IgG4-Related Disease. Dr. Yousaf is currently accepting new patients.

Advanced in IgG4-Related Disease
Dr. Joseph S. Spindler
Rheumatology
Advanced in IgG4-Related Disease
Dr. Joseph S. Spindler
Rheumatology
902 Frostwood Dr, Suite 150, 
Houston, TX 
 (0.1 miles away)
713-524-4494
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joseph Spindler is a Rheumatologist in Houston, Texas. Dr. Spindler is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Rheumatoid Pneumoconiosis, and Rheumatoid Lung Disease.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Neiman's expertise for a condition
ConditionClose
    • Distinguished
    • Fibromyalgia
      Dr. Neiman is
      Distinguished
      . Learn about Fibromyalgia.
      See more Fibromyalgia experts
    • Gout
      Dr. Neiman is
      Distinguished
      . Learn about Gout.
      See more Gout experts
    • Advanced
    • Ankylosing Spondylitis
      Dr. Neiman is
      Advanced
      . Learn about Ankylosing Spondylitis.
      See more Ankylosing Spondylitis experts
    • Axial Spondyloarthritis (AxSpA)
      Dr. Neiman is
      Advanced
      . Learn about Axial Spondyloarthritis (AxSpA).
      See more Axial Spondyloarthritis (AxSpA) experts
    • Bursitis
      Dr. Neiman is
      Advanced
      . Learn about Bursitis.
      See more Bursitis experts
    • Cutaneous Lupus Erythematosus (CLE)
      Dr. Neiman is
      Advanced
      . Learn about Cutaneous Lupus Erythematosus (CLE).
      See more Cutaneous Lupus Erythematosus (CLE) experts
    • Discoid Lupus Erythematosus (DLE)
      Dr. Neiman is
      Advanced
      . Learn about Discoid Lupus Erythematosus (DLE).
      See more Discoid Lupus Erythematosus (DLE) experts
    • IgG4-Related Disease
      Dr. Neiman is
      Advanced
      . Learn about IgG4-Related Disease.
      See more IgG4-Related Disease experts
    View All 25 Advanced Conditions
    • Experienced
    • Arthritis
      Dr. Neiman is
      Experienced
      . Learn about Arthritis.
      See more Arthritis experts
    • Behcet Disease
      Dr. Neiman is
      Experienced
      . Learn about Behcet Disease.
      See more Behcet Disease experts
    • Calcium Pyrophosphate Arthritis
      Dr. Neiman is
      Experienced
      . Learn about Calcium Pyrophosphate Arthritis.
      See more Calcium Pyrophosphate Arthritis experts
    • Dermatomyositis
      Dr. Neiman is
      Experienced
      . Learn about Dermatomyositis.
      See more Dermatomyositis experts
    • Eales Disease
      Dr. Neiman is
      Experienced
      . Learn about Eales Disease.
      See more Eales Disease experts
    • Felty Syndrome
      Dr. Neiman is
      Experienced
      . Learn about Felty Syndrome.
      See more Felty Syndrome experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved